Considering the effectiveness and low cost of the electrochemical biosensor combined with the obtained data, usage of the biosensor and β2M as supplementary diagnostic tools potentially may improve the diagnostic accuracy in PCa. The gene discussed is B2M; the disease is posterior cortical atrophy.